Live from the NIH registry
Studies recruiting near Burlington right now
Top 25 of 761 recruiting studies, sorted by proximity — each links to its official registry page
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
UNC Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: GentiBio, Inc
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Obesity
Phase 3
Interventional 600 participants sought
Medication Mgmnt, LLC_Grnsboro — Greensboro, North Carolina (18.1 mi)
· Sponsor: Novo Nordisk A/S
Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)
Thoracic
N/A
Interventional 200 participants sought
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: UNC Lineberger Comprehensive Cancer Center
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
UNC Hospitals — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation
Rotator Cuff Tears, Rotator Cuff Injuries
Phase 4
Interventional 100 participants sought
University of North Carolina Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Brooke Army Medical Center
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Cook Research Incorporated
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
University of North Carolina (UNC) — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Synairgen Research Ltd.
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Bladder Cancer, Recurrent Bladder Cancer
N/A
Observational 408 participants sought
University of North Carolina — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: University of Washington
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
N/A
Interventional 24,000 participants sought
UNC Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: National Cancer Institute (NCI)
The Osteoarthritis Prevention Study
Osteoarthritis, Knee
N/A
Interventional 1,230 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Wake Forest University
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Cone Health Cancer Center — Greensboro, North Carolina (18.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
PharmQuest — Greensboro, North Carolina (18.1 mi)
· Sponsor: Novo Nordisk A/S
Neuroscience of Psychotherapy for Depression
Depression
N/A
Interventional 45 participants sought
Carolina Center for Neurostimulation — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: University of North Carolina, Chapel Hill
Resources for Optimizing Outcomes in Toddlers on the Spectrum
Autism Spectrum Disorder
N/A
Interventional 60 participants sought
Carolina Institute for Developmental Disabilities — Carrboro, North Carolina (24.8 mi)
· Sponsor: University of North Carolina, Chapel Hill
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: AstraZeneca
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Hematologic Malignancies
Phase 1, Phase 2
Interventional 160 participants sought
UNC School of Medicine, Division of Hematology — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Sellas Life Sciences Group
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 140 participants sought
University of North Carolina — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Eli Lilly and Company
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
Barrett Esophagus, Barretts Esophagus With Dysplasia
N/A
Interventional 2,298 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: University of Colorado, Denver
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: AstraZeneca
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 180 participants sought
The University of North Carolina Dermatology and Skin Cancer Center — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Organon and Co
mHealth for Early Psychosis Caregivers in Statewide Program Outreach
Caregiver, Caregiver Distress
N/A
Interventional 30 participants sought
UNC Department of Psychiatry — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: University of North Carolina, Chapel Hill
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
UNC Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: National Cancer Institute (NCI)
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 3
Interventional 380 participants sought
University of North Carolina /ID# 259854 — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: AbbVie
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Venous Thromboses, Venous Disease
N/A
Interventional 165 participants sought
University of North Carolina - Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: W.L.Gore & Associates